Authors:
Bruggemann, M
Droese, J
Bolz, I
Luth, P
Pott, C
von Neuhoff, N
Scheuering, U
Kneba, M
Citation: M. Bruggemann et al., Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR, LEUKEMIA, 14(8), 2000, pp. 1419-1425
Authors:
Dreger, P
Viehmann, K
von Neuhoff, N
Kruss, D
Glass, B
Kneba, M
Mitsky, P
Jopp, P
Rautenberg, P
Mills, B
Schmitz, N
Citation: P. Dreger et al., A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia, EXP HEMATOL, 28(10), 2000, pp. 1187-1196
Authors:
Dreger, P
Glass, B
Seyfarth, B
Humpe, A
Claviez, A
von Neuhoff, N
Suttorp, M
Schoch, R
Schmitz, N
Citation: P. Dreger et al., Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT, BONE MAR TR, 26(12), 2000, pp. 1361-1362
Authors:
Dreger, P
Viehmann, K
von Neuhoff, N
Glaubitz, T
Petzoldt, O
Glass, B
Uharek, L
Rautenberg, P
Suttorp, M
Mills, B
Mitsky, P
Schmitz, N
Citation: P. Dreger et al., Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery, BONE MAR TR, 24(2), 1999, pp. 153-161
Authors:
Dreger, P
Glass, B
Kuse, R
Sonnen, R
von Neuhoff, N
Bolouri, H
Kneba, M
Schmitz, N
Citation: P. Dreger et al., Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia, BR J HAEM, 106(1), 1999, pp. 115-118